CDK Global (CDK) Misses Q2 EPS by 6c, Revenues Miss; Offers FY21 EPS/Revenue Guidance

CDK Global (NASDAQ: CDK) reported Q2 EPS of $0.59, $0.06 worse than the analyst estimate of $0.65. Revenue for the quarter came in at $406.3 million versus the consensus estimate of $418.77 million.

"I'm extremely proud of what our teams accomplished, as we launched Neuron, our data intelligence platform and continued our initiatives to bring even more value to our dealer and OEM customers with new products and innovative technology. The efforts of our ongoing customer-first strategy resulted in achieving a new company record high net promoter score," said Brian Krzanich, CDK chief executive officer. "We remain very optimistic about our strategy to focus on growth opportunities in North America, giving us confidence we can deliver sustainable growth and create long-term shareholder value."

"We reached the highest site count in company history and increased revenue per site in both our auto and adjacency businesses, while we continue to deal with the broader uncertainty of the macro environment," said Eric Guerin, CDK chief financial officer. "As we move toward closing the sale of the CDK International business later this third quarter, I’m quite pleased with our strong financial position and ability to implement our growth strategy."

GUIDANCE:

CDK Global sees FY2021 EPS of $2.45-$2.75, versus the consensus of $2.66. CDK Global sees FY2021 revenue of $1.66-1.71 billion, versus the consensus of $1.68 billion.

For earnings history and earnings-related data on CDK Global (CDK) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Aon names interim CFO as Edmund Reese exits the firm
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance